Literature DB >> 20974887

Prevalence of Staphylococcus aureus and lack of its lytic bacteriophages in the anterior nares of patients and healthcare workers at a rural clinic.

Vijay H Aswani1, Sanjay K Shukla.   

Abstract

BACKGROUND: Nearly 30% of people in the United States are colonized with Staphylococcus aureus and 1% to 2% with methicillin-resistant Staphylococcus aureus (MRSA) in the anterior nares. However, it is not known if lytic bacteriophages against S. aureus are present in the anterior nares, and if they are, what the prevalence rate is, or if they interfere with S. aureus colonization. The aim of this study was to determine the prevalence of nasal carriage of S. aureus and MRSA and to screen for S. aureus lytic bacteriophages in healthcare environment workers and ambulatory patients.
METHODS: We enrolled 202 individuals into this study. The anterior nares were swabbed to isolate S. aureus, MRSA, and any lytic S. aureus bacteriophages that may be present. Putative S. aureus colonies on blood agar plates were identified using gram stain, catalase and coagulase tests, and confirmed by S. aureus-specific PCR. Presence of staphylococcal lytic bacteriophages were screened by a plaque assay technique using a methicillin-sensitive reference S. aureus strain ATCC 29213.
RESULTS: Of the 49 (24%) individuals who screened positive for S. aureus, two (1%) were positive for MRSA. None of the samples were positive for lytic bacteriophages against S. aureus. Subgroup analysis found no significant difference in the prevalence of S. aureus in the house staff compared to other healthcare environment workers or ambulatory patients of the clinic. Similarly, no significant difference in colonization was noted across the population with respect to age, sex, body mass index, or presence of diabetes mellitus.
CONCLUSION: The prevalence of nasal carriage of S. aureus and MRSA in the studied population was 24% and 1%, respectively, similar to the rate of prevalence in the United States. The study also showed that the anterior nares do not seem to harbor lytic bacteriophages against S. aureus.

Entities:  

Mesh:

Year:  2010        PMID: 20974887      PMCID: PMC3134439          DOI: 10.3121/cmr.2010.954

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  38 in total

1.  Metagenomic analyses of an uncultured viral community from human feces.

Authors:  Mya Breitbart; Ian Hewson; Ben Felts; Joseph M Mahaffy; James Nulton; Peter Salamon; Forest Rohwer
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

2.  Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

Authors:  Catherine C Cowie; Keith F Rust; Danita D Byrd-Holt; Mark S Eberhardt; Katherine M Flegal; Michael M Engelgau; Sharon H Saydah; Desmond E Williams; Linda S Geiss; Edward W Gregg
Journal:  Diabetes Care       Date:  2006-06       Impact factor: 19.112

Review 3.  The potential of phages to prevent MRSA infections.

Authors:  Nicholas H Mann
Journal:  Res Microbiol       Date:  2008-04-26       Impact factor: 3.992

4.  Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002.

Authors:  Matthew J Kuehnert; Deanna Kruszon-Moran; Holly A Hill; Geraldine McQuillan; Sigrid K McAllister; Gregory Fosheim; Linda K McDougal; Jasmine Chaitram; Bette Jensen; Scott K Fridkin; George Killgore; Fred C Tenover
Journal:  J Infect Dis       Date:  2005-12-15       Impact factor: 5.226

5.  Emerging high-level mupirocin resistance among MRSA isolates in Ireland.

Authors:  Angela Rossney; S O'Connell
Journal:  Euro Surveill       Date:  2008-04-03

6.  Isolation and characterization of two anti-staphylococcal bacteriophages specific for pathogenic Staphylococcus aureus associated with bovine infections.

Authors:  S O'Flaherty; R P Ross; J Flynn; W J Meaney; G F Fitzgerald; A Coffey
Journal:  Lett Appl Microbiol       Date:  2005       Impact factor: 2.858

7.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

8.  Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004.

Authors:  Rachel J Gorwitz; Deanna Kruszon-Moran; Sigrid K McAllister; Geraldine McQuillan; Linda K McDougal; Gregory E Fosheim; Bette J Jensen; George Killgore; Fred C Tenover; Matthew J Kuehnert
Journal:  J Infect Dis       Date:  2008-05-01       Impact factor: 5.226

9.  The pneumococcal pilus predicts the absence of Staphylococcus aureus co-colonization in pneumococcal carriers.

Authors:  Gili Regev-Yochay; Marc Lipsitch; Alan Basset; Ethan Rubinstein; Ron Dagan; Meir Raz; Richard Malley
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

10.  Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.

Authors:  Jeffrey C Jones; Theodore J Rogers; Peter Brookmeyer; William Michael Dunne; Gregory A Storch; Craig M Coopersmith; Victoria J Fraser; David K Warren
Journal:  Clin Infect Dis       Date:  2007-07-13       Impact factor: 9.079

View more
  3 in total

1.  Staphylococcus epidermidis bacteriophages from the anterior nares of humans.

Authors:  Vijay Aswani; Denise M Tremblay; Sylvain Moineau; Sanjay K Shukla
Journal:  Appl Environ Microbiol       Date:  2011-09-16       Impact factor: 4.792

2.  Within-host diversity of MRSA antimicrobial resistances.

Authors:  Kinga I Stanczak-Mrozek; Anusha Manne; Gwenan M Knight; Katherine Gould; Adam A Witney; Jodi A Lindsay
Journal:  J Antimicrob Chemother       Date:  2015-05-08       Impact factor: 5.790

3.  Complete Genome Sequence of a Staphylococcus epidermidis Bacteriophage Isolated from the Anterior Nares of Humans.

Authors:  Vijay H Aswani; Denise M Tremblay; Sylvain Moineau; Sanjay K Shukla
Journal:  Genome Announc       Date:  2014-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.